29.03.2018
RHÖN-KLINIKUM AG DE0007042301
DGAP-News: RHÖN-KLINIKUM AG: Press Conference Full Year Results 2017 in Frankfurt am Main on 29 March 2018
DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Final Results/Final Results
RHÖN-KLINIKUM AG: Press Conference Full Year Results 2017 in Frankfurt am
Main on 29 March 2018
29.03.2018 / 07:00
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Corporate News
Bad Neustadt/Saale, 29 March 2018
RHÖN-KLINIKUM AG:
Press Conference Full Year Results 2017 in Frankfurt am Main on 29 March
2018
- Guidance for 2017 fully met
- Patient numbers rise by 2.8 percent to 836,387
- Revenues increase by approx. 3 percent to Euro 1.21 billion
- EBITDA stands at Euro 97.8 million
- Net consolidated profit amounts to Euro 36.7 million
- Dividend proposal in the amount of Euro 0.22 per share
- Outlook for 2018: focus on profitability to increase noticeably, campus
flagship project in
Bad Neustadt and intensifying the use of digital instruments throughout the
corporate group
RHÖN-KLINIKUM AG held its ground in financial year 2017 with solid organic
growth despite a difficult market environment and regulatory hurdles. The
envisioned revenue and EBITDA targets for 2017 were fully met.
A total of 836,387 patients were treated in the company's hospitals in the
past financial year (2016: 813,747). Corporate revenues stood at Euro 1.21
billion and rose by approx. 3 percent compared with the previous year (2016:
Euro 1.18 billion).
The figure for earnings before interest, taxes, depreciation and
amortization (EBITDA) of Euro 97.8 million is lower when compared with the
previous year (2016: Euro 156.9 million): the drop amounts to 14.9 percent
following adjustments for subsequent transaction effects of Euro 42 million
from releasing provisions in connection with the Helios transaction. The
trend, which has continued for years, of a diverging gap between revenues
and costs due to the high budgetary and regulatory pressure continues.
Material cost-intensive services, in which RHÖN-KLINIKUM AG specializes as a
provider of predominantly high-quality, complex medical care, are not
adequately remunerated. The so-called catalogue effect, which is
particularly reflected in cardiological and special orthopaedic services, as
well as other regulatory interventions have a negative effect on the
company's financial figures.
The net consolidated profit amounted to Euro 36.7 million (2016: Euro 58.6
million): The high percentage changes are due to the transaction effects
mentioned above and an offsetting value adjustment of EUR 35.5 million in
connection with the Marburg Ion Beam Therapy Center from fiscal year 2016. A
total of 16,688 employees were working in the company's facilities as of
31st December 2017 (31st December 2016: 16,486). The hospitals are each
among the largest employers of their respective regions. The greatest growth
in the number of employees was recorded by the two university hospitals in
Giessen and Marburg.
"Despite the increased revenues we still cannot be satisfied with our
profitability. We therefore continue to set ourselves ambitious targets. The
enhancement program which has been running throughout the corporate group
since the middle of last year will show initial positive effects in our
operative figures in 2018 and counteract the unsatisfactory remuneration for
services with high material costs as well as the trend towards out-patients.
The agreement on separate accounting for our university hospitals in Giessen
and Marburg (UKGM) will have a one-off positive effect of approx. Euro 20
million on our EBITDA: for the first time we shall receive satisfactory
remuneration for our expenditure on research and teaching due to the
conclusion of the agreement with a positive effect on our margins. We are
very confident that we shall achieve the intended EBITDA range of Euro 117.5
million to Euro 127.5 million for financial year 2018," stated Stephan
Holzinger, CEO of RHÖN-KLINIKUM AG.
RHÖN Campus Strategy and Digitalization in Focus
The RHÖN campus strategy stands for excellent medical care for patients in
rural areas. A forward-looking healthcare concept which is tailored to the
patient is being created by linking the different out-patient and in-patient
medical services across all the various sectors. Our company is setting new
standards with the current reconstruction of the campus in Bad
Neustadt/Saale.
"Our new campus is much more than just a building measure. We are creating
more effective and efficient structures in the provision of healthcare and
improving patient flow. We are utilising the advantages of a fully
digitalized hospital with state-of-the-art IT technology. The treatment of
our patients is therefore faster, safer and of a higher quality. With the
campus in Bad Neustadt/Saale which will be completed at the end of 2018 we
shall take a unique and highly attractive prototype into service. We are
positioning ourselves on the hospital market with this forward-looking model
where not only RHÖN-KLINIKUM AG and its patients will profit from its
increase in efficiency but also the cost-bearers, e.g. by avoiding double
examinations," stated Holzinger.
Outlook
For the current financial year 2018 we expect revenues in the amount of Euro
1.24 billion plus/minus 5 percent. A continuing burden on our company
remains regulatory legislation such as lower remuneration for services with
high material costs (especially cardiological services) or the discount for
lower overheads on additional services.
For 2018 we expect a much higher amount for earnings before interest, taxes,
depreciation and amortization (EBITDA) of between Euro 117.5 million and
Euro 127.5 million in comparison with 2017, EBITDA being positively
influenced by the agreement with UKGM regarding separate accounting as well
as other effects.
The Board of Management and Supervisory Board shall propose to this year's
Annual General Meeting on 6th June 2018 in Bad Neustadt/Saale the
distribution of the net consolidated profit in the form of a dividend in the
amount of Euro 0.22 per non-par share to the shareholders. This corresponds
to a dividend payout ratio of approx. 40 percent. With this ratio
RHÖN-KLINIKUM AG safeguards its medium-term ability to make investments yet
also allows its shareholders to participate in the future success of the
Company.
---------------------------------------------------------------------------------------------
RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The
hospital group offers excellent medical care with a direct link to
universities and research institutes. More than 830,000 patients are treated
every year at the five group hospitals located in Bad Berka, Bad Neustadt,
Frankfurt (Oder), Giessen and Marburg where approx. 16,700 employees work.
With the RHÖN campus concept the Company is currently implementing a new and
forward-looking project which raises fully comprehensive healthcare in rural
areas to a new level of excellence and is geared to the growing needs of
patients. www.rhoen-klinikum-ag.com
Contact
RHÖN-KLINIKUM AG
Head of Investor Relations
Mr. Julian Schmitt
Telephone: +49 9771 65-1536 | E-Mail: [email protected]
---------------------------------------------------------------------------
29.03.2018 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: RHÖN-KLINIKUM AG
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart, Tradegate Exchange
End of News DGAP News Service
---------------------------------------------------------------------------
670187 29.03.2018
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
RHÖN-KLINIKUM AG ISIN: DE0007042301 können Sie bei EQS abrufen
Pflegeeinrichtungen , 704230 , RHK , XETR:RHK